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Abstract
 The multi-subunit homotypic fusion and vacuole proteinBackground:
sorting (HOPS) membrane-tethering complex is involved in regulating the
fusion of late endosomes and autophagosomes with lysosomes in
eukaryotes. The C-terminal regions of several HOPS components have
been shown to be required for correct complex assembly, including the
C-terminal really interesting new gene (RING) zinc finger domains of HOPS
components VPS18 and VPS41. We sought to structurally characterise the
putative C-terminal zinc finger domain of VPS39, which we hypothesised
may be important for binding of VPS39 to cellular partners or to other HOPS
components.
We recombinantly expressed, purified and solved the crystalMethods: 
structure of the proposed zinc-binding region of VPS39.
 In the structure, this region forms an anti-parallel β-hairpin that isResults:
incorporated into a homotetrameric eight-stranded β-barrel. However, the
fold is stabilised by coordination of zinc ions by residues from the
purification tag and an intramolecular disulphide bond between two
predicted zinc ligands.
We solved the structure of the VPS39 C-terminal domainConclusions: 
adopting a non-native fold. Our work highlights the risk of non-native folds
when purifying small zinc-containing domains with hexahistidine tags.
However, the non-native structure we observe may have implications for
rational protein design.
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Introduction
Eukaryotic cells use an interconnected system of membrane-
bound compartments to partition intracellular space, allowing a 
multitude of biological reactions to proceed simultaneously in 
distinct chemical environments. The primary carriers of mac-
romolecules between these compartments are vesicles, which 
bud from donor membranes in a cargo-dependent manner 
before fusing with an acceptor membrane at the destination com-
partment. Membrane fusion in the endomembrane system is 
critically dependent on SNARE (soluble N-ethylmaleimide sen-
sitive factor attachment protein receptor) proteins, the co-folding 
of which on opposing membranes provides the energy for 
membrane bilayer mixing and thus vesicle fusion1. SNARE 
activity is tightly regulated by both Sec1/Munc18 family pro-
teins, which bind directly to SNAREs, and by multi-protein 
‘tethering’ complexes that bring vesicles into close apposition 
to allow the physical contact of SNARE proteins on opposing 
membranes2. The conserved multi-subunit tethering complexes 
CORVET (class C core vacuole/endosome tethering) and HOPS 
(homotypic fusion and vacuole protein sorting) combine both 
of these activities by incorporating the Sec1/Munc18 family 
protein VPS33A3–5. CORVET mediates homotypic fusion of 
early endosomes6, while HOPS mediates heterotypic fusion of 
late endosomes with lysosomes4,5 and autophagosomes with 
lysosomes7–9.
The human CORVET and HOPS complexes share four 
conserved core subunits (VPS11, VPS16, VPS18, VPS33A), 
known collectively as the class C core3,10. Two additional, 
unique subunits direct each complex to its respective mem-
brane target; VPS8 and TRAP1 direct CORVET to Rab5-positive 
membranes6,11, while VPS41 and VPS39 direct HOPS to 
Rab7-positive membranes12,13. Previous studies using truncation 
mapping have highlighted the importance of the C-terminal 
regions of HOPS components in assembly of the HOPS 
complex3,14–16. Recruitment of VPS41 to the class C core is 
facilitated by the C-terminal RING (really interesting new 
gene) domains of VPS18 and VPS41, which interact 
directly15. RING domains are a type of zinc finger, with an 
eight-residue motif containing six or seven cysteine residues 
and one or two histidine residues that coordinate two zinc 
ions17–19. RING domains may be involved in protein-protein, 
protein-lipid or protein-nucleic acid interactions, and have a wide 
variety of cellular functions17–19.
The C terminus of VPS39 contains a putative zinc finger 
domain15 (Figure 1A), the closest homologue of which is the zinc 
finger domain of Saccharomyces cerevisiae protein Pcf11 
(Figure 1B)20. This putative VPS39 zinc finger domain is much 
shorter than those of VPS18 and VPS41, and is predicted to 
bind only one zinc ion via four ligands15. Given that VPS41 is 
recruited to the class C core by an interaction between two zinc 
finger domains14, and that the C-terminal region of VPS39 is 
required for its interaction with VPS1116, we hypothesised 
that the putative VPS39 C-terminal zinc finger domain may be 
required for its incorporation into the HOPS complex or for 
binding other cellular partners.
There is currently no high-resolution structural information 
available for any region of human VPS39, nor its yeast 
homologue vps39 (a.k.a. vam6). An atomic-resolution structure 
of the putative VPS39 zinc finger domain may further our under-
standing of HOPS complex assembly and function. We solved 
the structure of crystals formed by the VPS39 zinc finger domain 
to 2.9 Å resolution, but observed that the protein had adopted a 
non-native fold mediated by interactions between zinc ions and 
the purification tag.
Methods
Protein expression and purification
Residues 840–875 of human VPS39 isoform 2 (UniProt ID 
Q96JC1-2), corresponding to the putative C-terminal zinc 
finger domain, were cloned into pOPTH, (derived from pOPT21), 
with an N-terminal MetHis6 purification tag and expressed in 
Escherichia coli strain BL21(DE3) pLysS. Bacteria were cultured in 
2×TY medium, recombinant proteins being expressed overnight 
at 22°C following addition of 0.4 mM isopropyl β-d-1-thioga-
lactopyranoside. Cultures were harvested by centrifugation at 
5000×g for 15 min and cell pellets were stored at -80°C.
Bacterial cell pellets were resuspended in lysis buffer (20 mM 
tris pH 7.5, 500 mM NaCl, 20 mM imidazole pH 7.5, 0.5 mM 
MgCl2, 1.4 mM β-mercaptoethanol, 0.05% Tween-20) supple-
mented with 400 U bovine pancreas DNase I (Merck) and 200 μL 
EDTA-free protease inhibitor cocktail (Merck) at 4°C. Cells were 
lysed using a TS series cell disruptor (Constant Systems) at 24 
kPSI and the lysate was cleared by centrifugation at 40,000×g 
for 30 min at 4°C. The cleared lysate was incubated with Ni2+-
nitrilotriacetic acid agarose resin (Qiagen) equilibrated in wash 
buffer (20 mM tris pH 7.5, 500 mM NaCl, 20 mM imidazole 
pH 7.5) for 1 h at 4°C before being applied to a column and 
washed with >10 column volumes of wash buffer. Bound pro-
tein was eluted using elution buffer (20 mM tris pH 7.5, 500 mM 
NaCl, 250 mM imidazole pH 7.5), concentrated, and further 
purified by size-exclusion chromatography (SEC) using an S75 
16/600 column (GE Healthcare) equilibrated in SEC buffer (20 
mM tris pH 7.5, 200 mM NaCl, 1 mM dithiothreitol (DTT)). 
Purified VPS39 was concentrated, snap-frozen in liquid nitro-
gen as small aliquots (<100 μL), and stored at -80°C. Protein 
concentrations were estimated from absorbance at 280 nm 
using a calculated extinction coefficient22 for VPS39(840–875), 
assuming all cysteines were reduced.
X-ray crystallography
VPS39(840–875) was crystallised in sitting drops by mixing 
200 nL of 19.4 mg/mL protein in SEC buffer with 200 nL of res-
ervoir solution (100 mM HEPES pH 7.5, 200 mM ammonium 
acetate, 45% (v/v) 2-methyl-2,4-pentanediol (MPD)) and equili-
brating against 80 μL of reservoir at 20°C for 30 months. The 
VPS39 crystal was cryo-cooled by plunging into liquid nitro-
gen, no cryopreservant being added as the high concentration of 
MPD in the reservoir solution was predicted to provide 
sufficient cryoprotection. Diffraction data were recorded at 
100 K on a Pilatus 6M-F detector (Dectris) at Diamond Light 
Source beamline I04. Data were collected in three sweeps, as 
shown in Table 1.
Images were processed using DIALS version 1.14.1323 then 
CCP4 suite version 7.0.07824 programs POINTLESS version 
1.11.2125 and AIMLESS version 0.7.426 as implemented by the 
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xia2 version 0.5.902 data processing pipeline27. Data collec-
tion statistics are shown in Table 2. Two-wavelength multiple 
anomalous dispersion analysis was performed using the CCP4 
suite version 7.1.00124 CRANK2 version 2.0.229 automated 
experimental phasing pipeline28, with substructure determi-
nation performed with SHELXD version 2019/129, density 
modification performed with Parrot version 0.830, and iterative 
model building and refinement performed with Buccaneer 
version 1.131,32 and Refmac5 version 5.8.025833. Cycles of itera-
tive manual building with COOT version 0.8.934 and TLS 
plus positional refinement using Refmac5 version 5.8.025833 
with local non-crystallographic symmetry (NCS) restraints were 
initially performed using the high-energy remote wavelength 
dataset (Table 2). Building was assisted by the use of real-time 
molecular dynamics-assisted model building and map fitting 
with ISOLDE version 1.0b335. To ameliorate radiation damage 
evident in the structure, later stages of refinement were per-
formed using the first 300 frames of the second peak wavelength 
dataset (Peak 2; Table 1), processed using xia2 as above with the 
same set of reflections kept ‘free’ for cross-validation36. Final 
cycles of refinement were performed using autoBUSTER 
version 2.10.337 with local NCS restraints and bond length/
angle restraints for zinc ligands to ensure chemically-plausible 
zinc coordination38. The quality of the model was moni-
tored throughout refinement using MolProbity version 4.5.139 
and the validation tools in COOT version 0.8.934. Refinement 
statistics are shown in Table 2. Molecular images were produced 
in PyMOL 2.4.0a0 Open-Source40 and figures were composed in 
Inkscape version 1.041. VPS39 C-terminal domain residues 
predicted to bind zinc were identified via generation of a 
homology model using I-TASSER version 5.142 with the 
structure of S. cerevisiae Pcf11 (PDB ID: 2NAX)20 as the 
template.
Results
The C-terminal region of human VPS39 contains a putative 
zinc finger domain (residues 840–875, Figure 1A) with four 
predicted zinc-binding residues (Cys841, Cys844, His863, 
Cys866). These residues are predicted to coordinate a single 
zinc ion based on homology to the zinc finger domain of 
S. cerevisiae protein Pcf11 (Figure 1B). The coordinates for 
this theoretical model are available (see Underlying data)43.
The VPS39 C-terminal domain was expressed with an N-termi-
nal His6 tag in E. coli and purified using nickel affinity capture 
followed by SEC. The protein eluted from SEC as a single, 
symmetrical peak near the end of the elution profile (Figure 1C), 
consistent with expectations for a small folded protein domain. 
Analysis of the eluted fractions by SDS-PAGE showed a single 
predominant band that migrated as would be expected for the 
VPS39 zinc finger domain (5.1 kDa; Figure 1C), with a much 
less intense band at higher apparent molecular mass that was 
presumed to be a small amount of SDS-resistant VPS39 dimer. 
Figure 1. Purification and crystallisation of the VPS39 zinc finger domain. (A) Predicted domain organisation of human VPS39, showing 
the position of the short C-terminal zinc finger domain that is the focus of this study (CNH, citron homology domain; CHCR, clathrin heavy 
chain repeat; Zn, zinc finger domain). Predicted domain boundary residue numbers are indicated above the schematic. (B) Homology model 
of VPS39 C-terminal domain based on S. cerevisiae Pcf11 zinc finger domain. Putative zinc ligands are shown as sticks and the approximate 
position of a bound zinc ion is indicated by a grey sphere. (C) SEC elution profile of purified VPS39 C-terminal domain (UV absorbance: solid 
blue line). Fractions that were analysed by SDS-PAGE (inset) are highlighted in light blue. (Inset). SDS-PAGE analysis of SEC elution fractions 
35–39 (94.1–102.1 mL). Approximate positions of molecular weight markers are shown. (D) Crystal of purified VPS39 C-terminal domain 
mounted on beamline I04 at the Diamond Light Source (scale bar = 100 μm; position of X-ray beam: red crosshair).
Table 1. Data collection strategy. Data were recorded from a single 
crystal in the order Peak 1, Peak 2 and then High-energy remote.
Dataset Peak 1 Peak 2 High-energy remote
Wavelength (Å) 1.2810 1.2810 0.9795
Exposure (s) 0.5 0.2 0.2
X-ray transmission (%) 3.0 29.9 52.4
Oscillation per frame (°) 0.2 0.2 0.2
Total number of frames 900 900 1800
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Table 2. Data collection and refinement statistics. The ‘Peak’ column describes the 
merged diffraction data from sweeps ‘Peak 1’ and ‘Peak 2’ (Table 1) used for structure 
solution. The ‘Peak(1–300)’ column describes the subset of ‘Peak 2’ diffraction data 
used for structure refinement. Values in parentheses describe the high-resolution shell.
Dataset Peak High energy remote Peak(1–300)
Data collection
Wavelength (Å) 1.28096 0.97949 1.28096
Space group P 42 2 2 P 42 2 2 P 42 2 2
Cell dimensions
      a, b, c (Å) 104.17, 104.17, 
39.43
104.17, 104.17, 39.43 104.18, 104.18, 
39.42
      α, β, γ (°) 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution (Å) 73.65–3.07 
(3.12–3.07)
28.89–2.98 
(3.03–2.98)
46.59–2.90 
(2.95–2.90)
Total reflections 97,700 (2367) 116,580 (4961) 21,099 (1058)
Unique reflections 4399 (197) 4793 (247) 5148 (247)
Completeness (%) 100.0 (100.0) 100.0 (100.0) 99.3 (100.0)
Anomalous completeness 
(%)
100.0 (100.0) 99.9 (100.0) 96.8 (99.0)
Multiplicity 22.2 (12.0) 24.3 (25.7) 4.1 (4.3)
Anomalous multiplicity 12.6 (6.5) 13.7 (14.1) 2.3 (2.3)
Rmerge 0.121 (0.844) 0.124 (1.154) 0.075 (1.178)
Rpim 0.027 (0.252) 0.026 (0.231) 0.041 (0.632)
CC1/2 0.998 (0.939) 0.999 (0.944) 0.966 (0.602)
CCanom 0.699 (0.011) 0.403 (0.020) 0.580 (-0.144)
Mean I/σ(I) 16.4 (2.4) 16.0 (3.1) 10.1 (0.9)
Refinement
Resolution (Å) 46.59–2.90 
(2.98–2.90)
Reflections
    Working set 4853 (350)
    Test set 286 (18)
Rwork 0.2376 (0.2535)
Rfree 0.2686 (0.3028)
No. of atoms
  Protein 922
  Solvent 1
  Zinc ions 3
Root mean square 
deviation
    Bond lengths (Å) 0.008
    Bond angles (°) 1.07
MolProbity score 2.05
Ramachandran favoured 
(%)
92.73
Ramachandran outliers 
(%)
0.00
Poor rotamers (%) 4.90
Mean B value (A2) 122.04
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The protein was concentrated and sparse matrix crystallisation 
screening was performed, but no crystals were obtained in the 
following six weeks. Approximately 30 months later, the crys-
tallisation trays were re-inspected prior to disposal and a single 
crystal was observed (Figure 1D). This crystal was harvested 
and diffraction data were recorded at two wavelengths (Table 2), 
allowing the structure of the VPS39 zinc finger domain to be 
solved using anomalous dispersion signal from the incorporated 
zinc ions. The model was initially refined against the high-
energy data, but later stages of the refinement proved chal-
lenging because map features were indistinct and loop 
density was poor. We were concerned that intense X-ray expo-
sure during data collection at the peak wavelength, where the 
zinc ions would have a large X-ray absorption cross-section44, 
may have caused radiation damage. The final stages of refine-
ment were thus performed using data recorded in the first 300 
frames of the second sweep at the peak wavelength (Table 1 and 
Table 2), which represented the best compromise between 
total X-ray exposure/damage and data redundancy/resolution. 
The structure was refined to 2.90 Å resolution with residuals 
R = 0.238, Rfree = 0.269 and good stereochemistry, with an 
overall MolProbity score39 of 2.05 (Table 2). The structure is 
available under PDB ID: 6ZE9; raw diffraction images, 
crystallographic datasets and X-ray fluorescence scans are 
available (see Underlying data)45.
The asymmetric unit contains three copies of the VPS39 
C-terminal domain: two full-length copies (residues 840–875; 
purple and teal in Figure 2A) and a third copy spanning resi-
dues 840–869 (blue in Figure 2A). The remaining C-terminal 
residues of the third copy are absent from the electron 
density and presumably disordered. Each copy of the VPS39 
C-terminal domain forms an antiparallel β-hairpin, with residues 
849–860 forming a loop linking the two β-strands (Figure 2A). 
Strikingly, the VPS39 C-terminal domains are all organised 
around crystallographic symmetry axes such that they form 
eight-stranded β-barrels (Figure 2B). There are two distinct 
homotetramers formed: the first comprises two NCS-related 
chains that interact with two additional chains that are related by 
crystallographic two-fold rotational symmetry (Figure 2C), 
while the second homotetramer is formed by a single VPS39 
C-terminal domain interacting with three additional chains that 
are related by two orthogonal two-fold crystallographic symmetry 
axes (Figure 2D).
The asymmetric unit contains three zinc ions, consistent with 
the four predicted zinc ligands in each VPS39 copy based on 
homology to Pcf11 (Figure 1B). All zinc ions have tetrahedral 
geometry. However, only one of the predicted zinc ligands 
(Cys844) is involved in zinc ion coordination (Figure 2E). Of 
the remaining predicted zinc ligands, Cys841 and Cys866 had 
become oxidised to form an intramolecular disulphide 
bond in each VPS39 molecule (Figure 2F) and the final 
predicted ligand (His863) is not in close proximity to the zinc 
ions. Instead, the remaining zinc ligands are provided by two 
histidine side chains from the MetHis6 purification tag (His-3 
and His-1) and the terminal carboxylate group of the polypep-
tide chain (Thr875) or a water molecule (Figure 2G). As 
two of the ligands for each zinc ion derive from the affinity 
purification tag and the fold of the VPS39 C-terminal domain 
that we observe differs significantly from that of the closest 
sequence homologue (compare Figure 1B and Figure 2A), we 
conclude that the observed fold is non-native.
Discussion
We present the crystal structure of the human VPS39 zinc 
finger domain in a non-native fold. In the structure, three 
copies of the VPS39 C-terminal domain in the asymmetric unit 
(Figure 2A) combine with symmetry-related chains to form two 
similar, homotetrameric, eight-stranded β-barrels (Figure 2C, D). 
In each copy of VPS39, two of the residues predicted to bind 
zinc ions (Cys844 and Cys866; Figure 2E) instead form 
intramolecular disulphide bonds (Figure 2F), with the remaining 
zinc ligands provided by side chains from the N-terminal His6 
purification tag and the carboxylate group of the polypeptide 
chain or a water molecule (Figure 2G).
Structural characterisation of VPS39 was undertaken to com-
plement a yeast two-hybrid screen of HOPS component zinc 
finger domains, including the putative VPS39 zinc finger domain, 
with the aim of identifying cellular binding proteins15. However, 
as pull-down experiments failed to validate any of the potential 
interactions that were tested, structural characterisation of the 
VPS39 C-terminal domain was not actively pursued. After 
30 months, as the crystallisation trials were being discarded, a 
single VPS39 C-terminal domain crystal was identified and 
used for successful structure determination. It seems very likely 
that the non-native fold that we observed arose from re-folding 
of the purified VPS39 C-terminal domain during the extended 
crystallisation experiment. The elution of freshly purified VPS39 
C-terminal domain from SEC (Figure 1C) was consistent with 
this small protein being monomeric, whereas the β-barrels of 
VPS39 in the crystal structure would be likely to elute much 
earlier, although we concede that formation of a β-barrel fold 
from the outset remains possible.
Refolding of the VPS39 C-terminal domain to form the observed 
β-barrels is likely to have been promoted via the concerted 
actions of zinc binding by the purification tag, disulphide bond 
formation and formation of β-sheets with unsatisfied backbone 
hydrogen bonds. The histidine side chains from the MetHis6 
purification tag could have competed with Cys841 and Cys866 for 
coordination of the zinc ions, thereby liberating the side chains 
of these two cysteine residues. While the VPS39 C-terminal 
domain was purified under reducing conditions (the SEC buffer 
being supplemented with 1 mM DTT), it is likely that the 
contents of the crystallisation drops became oxidised during 
their extended incubation. The liberated cysteine side chains may 
thus have formed the observed intramolecular disulphide bond, 
prohibiting them from competing with the MetHis6 tag side 
chains for re-binding to the zinc ion. Either or both molecular 
rearrangements could have promoted re-folding of the pro-
tein backbone to adopt the extended β-hairpin fold observed 
in this structure. The refolded VPS39 β-sheets would have 
unsatisfied backbone hydrogen bonds, which could have 
promoted similar refolding of additional VPS39 molecules (akin 
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to nucleation of amyloid fibrils). Such stimulated refolding could 
promote further exchange of zinc ligands and disulphide bond 
formation, acting as a ratchet to increase the pool of refolded 
VPS39 for crystallisation. The covalent interaction between 
β-barrels, mediated by the carboxy terminus of the polypeptide 
binding to the zinc ions, would have promoted stability of the 
crystal once nucleated.
While the structure presented here does not provide biological 
insight into the organisation or function of the putative 
VPS39 C-terminal zinc finger domain, there are still useful 
lessons to be learned. Firstly, nickel-affinity chromatography 
should be used with caution when purifying zinc-binding 
proteins as the similar chemical properties of zinc and nickel 
can lead to competition between purification tag residues and 
native zinc ligands for zinc ions. If this purification strategy 
is used, constructs should be engineered to include a protease 
cleavage site that can be used to remove the purification 
tag before downstream applications, particularly those 
involving long incubations such as crystallisation. We have 
previously reported structures where purification tag residues 
give rise to folding artefacts46 and where metal ions help 
mediate non-natural ‘swapped’ β-strand topologies of crys-
tallised molecules47. While His6 tags are generally benign for 
crystallisation and may indeed be beneficial in some cases48, 
caution should be exercised when using them to purify small 
zinc-containing domains.
The non-native β-barrel fold of the VPS39 C-terminal domain 
we observe here highlights the power of metal ion coordination 
Figure 2. Non-native structure of VPS39 C-terminal domain. (A) Three copies of the VPS39 C-terminal domain in the asymmetric unit, 
showing the antiparallel β-hairpin fold of each molecule. VPS39 is shown in ribbon representation with N and C termini shown. Cysteine 
sulphur atoms that form disulphide bonds are shown as yellow spheres and zinc ions are shown as grey spheres. Residues at the start and 
end of the loop that joins the two β-strands are indicated. (B) Unit cell of the VPS39 crystal lattice viewed along the c axis, showing eight 
stranded β-barrels formed by symmetry-related VPS39 chains. Selected symmetry axes (four-fold screw and two-fold rotation) are indicated 
using standard symmetry symbols. Incorporated zinc ions are shown as spheres. (C, D) Eight-stranded β-barrels formed by symmetry-related 
chains via a single crystallographic two-fold rotational symmetry axis (C) or two orthogonal two-fold rotational axes (D) are shown in ribbon 
representation. The unique VPS39 molecules from the asymmetric unit (A) are coloured blue/purple (C) or teal (D), with symmetry-related 
chains shown in light grey. Zinc ions coordinated by visible residues are shown as spheres. Two orthogonal views are shown, with symmetry 
axes shown in the bottom view where arrows represent a two-fold rotational axis in the plane of the image. (E) Schematic of the His6-VPS39 
zinc finger construct used in this study. (Top) Residues predicted to coordinate zinc ions by homology to S. cerevisiae Pcf11 (Figure 1B) 
are denoted with arrows. (Bottom) Residues that coordinate zinc ions in the crystal structure, including two residues from the purification 
tag, are denoted with arrows. Residues involved in the intramolecular disulphide bond in each chain are joined. (F) Enlarged views of 
intramolecular Cys841-Cys866 disulphide bond in each molecule of the VPS39 C-terminal domain. (G) Enlarged views of the three zinc ions 
in the asymmetric unit. VPS39 backbone atoms are shown as lines, with side chains involved in coordinating zinc ions shown as sticks. Bond 
lengths between zinc ions and relevant side chain atoms or water molecules are indicated.
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to strongly promote the stable (re)folding of proteins49, 
especially given the simple sequence requirements for 
efficient zinc binding (cysteine and histidine side chains or 
carboxylate groups). As a result, it is not uncommon for such 
features to arise spontaneously50,51, as has been previously 
noted in studies on directed protein evolution. Small zinc finger 
domains are often highly thermostable and tolerant to sequence 
changes outside of the zinc ligands52, which has led to their use 
as scaffolds for modular protein design53–55. Novel, non-native, 
metal ion-coordinating folds such as the VPS39 fold reported 
in this work are potentially less likely to interact with off-target 
cellular components when used as biologics56. The non-native 
fold of the VPS39 C-terminal domain presented here 
therefore expands the number of protein scaffolds available 
for rational therapeutic design.
Data availability
Underlying data
Protein Data Bank: Non-native fold of the putative VPS39 zinc 
finger domain. Accession number 6ZE9; https://identifiers.org/ 
rcsb/pdb:6ZE9.
Apollo: Crystallographic diffraction data for structure of the VPS39 
C-terminal domain. https://doi.org/10.17863/CAM.5386745.
This project contains raw diffraction images, crystallographic 
datasets and X-ray fluorescence scans.
Apollo: Theoretical model of the VPS39 zinc finger domain. 
https://doi.org/10.17863/CAM.5450343.
This project contains atomic coordinates for the theoretical 
model of the VPS39 zinc finger domain shown in Figure 1B.
Data hosted with Apollo are available under the terms of the 
Creative Commons Attribution 4.0 International license 
(CC-BY 4.0).
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